RecruitingNot ApplicableNCT07523477
Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis
Evaluation of Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis
Sponsor
Tanta University
Enrollment
64 participants
Start Date
Jun 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to evaluate the outcome of botulinum toxin A (BTX-A) injection for management of children with : A-Dysfunctional voiding who are not responding to traditional treatment. B-Refractory nocturnal enuresis.
Eligibility
Max Age: 18 Years
Inclusion Criteria3
- Children < 18 years.
- Both sexes.
- Patients with refractory nocturnal enuresis or dysfunctional voiding who are not responding to the traditional treatment.
Exclusion Criteria4
- Bleeding disorders.
- Neuromusclar disorder(e.g.,Myasthenia gravis).
- Patients who are not fit for anaesthesia.
- Active urinary tract infection (UTI).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGBotulinium Toxin-A
Patients will be injected with botulinium toxin-A
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07523477
Related Trials
Cerebral Palsy and the Study of Brain Activity During Motor Tasks
NCT018297241 location
Assessment of Language Comprehension and Learning in Children Attending Child Psychiatry Services (TICOALA-SOINS)
NCT072834581 location
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery
NCT074327111 location
Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D Deficiency
NCT076706111 location
Oral Versus Intravenous Magnesium on Emergence Delirium
NCT076558171 location